“amag-pharmaceuticals” Archives

in
Entry Author Date Location
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More 10/09/20 National
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
AMAG Pharma Sells Off Women’s Health Product in Planned Divestment 05/22/20 Boston
AMAG Pharma Cuts 140 Jobs Amid Restructuring, COVID-19 Disruptions 05/11/20 Boston
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More 03/06/20 National
Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More 01/10/20 National
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More 11/01/19 National
Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More 06/28/19 National
Bio Roundup: Gottlieb Exits, Bristol Defends, Biogen Buys & More 03/08/19 National
Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More 12/14/18 National
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More 01/08/16 Boston
Shkreli Leads $90M Round for New Startup, Turing Pharma 08/10/15 New York
East Coast Biotech Roundup: Vertex, Biogen, Sarepta, Juno, & More 07/06/15 Boston
Amag Seeks New Chapter With $700M Cord Blood Registry Purchase 06/30/15 Boston
East Coast Biotech Roundup: Intarcia, Atlas, Visterra, & More 10/06/14 Boston
East Coast Biotech Roundup: Enanta, NY Disruptors, Repligen, & More 01/24/14 Boston
East Coast Biotech Roundup: Juno, Editas, Celgene, & More 12/06/13 Boston
Visterra Adds $8M, Ex-Amag Execs, To Begin Clinical Push for Flu Antibody 12/02/13 Boston
Hard-Nosed Hedge Fund Chief Has Soft Spot for Rare-Disease Startup 04/03/12 New York
AMAG Stock Rises, Ariad Drug Shows Improved Safety, Rhythm Adds Merck Veteran as CEO, & More Boston-Area Life Sciences News 11/11/11 Boston
AMAG Shares Zoom on CEO Departure and Re-Org Plans 11/04/11 Boston
Celgene Pumps Up Acceleron, On-Q-ity CEO Goes to Roche Unit, MSMB Eyes Amag, & More Boston-Area Life Sciences News 08/05/11 Boston
New York Hedge Fund Makes $378 Million Bid for Amag in Attempt to Block Poorly Received Merger 08/03/11 Boston
Ksplice Bought By Oracle, Q2 Boston Deals Break $1B, General Catalyst Funds Airbnb, & More Boston-Area Deals News 07/27/11 Boston
Biogen Confirms Cambridge Move, Amag Merges With Allos, ACT Kicks Off Trials, & More Boston-Area Life Sciences News 07/22/11 Boston
Amag Makes Good on Acquisition Promise, But Wall Street Balks 07/20/11 Boston
Amag Eyes Rebound, Idera Surges On Despite Merck KGaA Drop, Verastem Snags $32M, & More Boston-Area Life Sciences News 07/15/11 Boston
Amag Rebounds from FDA Handwringing, Looks To Stock Pipeline Through Acquisitions 07/12/11 Boston
Page 1 of 2 next page »